Company news

Nanjing Well Pharmaceutical Group Co. Ltd. news in 2026

Nanjing Well Pharmaceutical Group Co. Ltd.'s news releases, calls and decks from 2026, newest first.

View company

(603351)"Nanjing Well Pharmaceutical Group Co., Ltd."Announcement on Repurchase of Shares through Call Auction Reaching 2% and Progress of Repurchase

November 12, 2026

(603351)"Nanjing Well Pharmaceutical Group Co., Ltd."Announcement on Progress in Repurchasing Shares through Call Auction

November 2, 2026

(603351)"Nanjing Well Pharmaceutical Group Co., Ltd."Announcement on Repurchase of Shares through Call Auction Reaching 1% and Progress of Repurchase

October 30, 2026

(603351)"Nanjing Well Pharmaceutical Group Co., Ltd."Report for Q3 2026

October 28, 2026

(603351)"Nanjing Well Pharmaceutical Group Co., Ltd."Announcement on Key Operating Data for Q3 2026

October 28, 2026

(603351)"Nanjing Well Pharmaceutical Group Co., Ltd."Announcement on Progress in Repurchasing Shares through Call Auction

October 22, 2026

(603351)"Nanjing Well Pharmaceutical Group Co., Ltd."Announcement on Initial Repurchase of Shares through Call Auction

October 14, 2026

(603351)"Nanjing Well Pharmaceutical Group Co., Ltd."Announcement on Addition of a Dedicated Securities Account for Share Repurchase

October 12, 2026

(603351)"Nanjing Well Pharmaceutical Group Co., Ltd."Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders of Unrestricted Shares Concerning Share Repurchase

October 8, 2026

Announcement on Key Operating Data for the First Half of 2026

August 21, 2026

Announcement on Share Pledge and Release of Share Pledge by Shareholder Holding More Than 5% of the Shares

August 19, 2026

Announcement on Completing Industrial and Commercial Change Registration and Obtaining Renewed Business License

June 9, 2026

Announcement on Implementation of Dividend Distribution for 2025

May 27, 2026

Announcement on Resolutions of the 1st Meeting of the 4th Board of Directors

May 19, 2026

Announcement on Outline of the Performance Briefing for 2025 and Q1 2026

May 13, 2026

Announcement on Convening Performance Briefing for 2025 and Q1 2026

April 27, 2026

Announcement on Result of Shareholding Reduction by Shareholder through Call Auction

April 13, 2026

Announcement on Pledge Extension of Shares Held by Shareholder with Over 5% Shares

March 25, 2026

Announcement on Pledge of Shares Held by Shareholder with Over 5% Shares

March 17, 2026

Announcement on Plan of Shareholding Reduction by Shareholders through Call Auction

February 26, 2026